Main pagePractices and sectorsSectors → Pharmaceuticals Industry

Pharmaceuticals Industry   

Today, the pharmaceuticals sector of Kazakhstan has entered the stage of its rapid development.  The country’s strategy aims to provide a powerful impetus for modernization of the national pharma industry and introduction of international drug production standards to Kazakhstan pharma companies.
Ongoing introduction of amendments to legislative acts regulating pharmaceutical activities is the most challenging issue for pharmaceutical sector participants. A continuous flow of novelties makes it hard to find the right direction in ever-changing environment.

We have vast experience of work with leading pharmaceutical companies and our clients benefit from such cooperation, as we truly understand the sector problems and can provide in-depth legal advice.

Our specialists advise on a wide range of legal issues, which arise in the day-to-day activities of pharmaceutical companies, including competition, regulatory and corporate issues, and intellectual property protection.  Our knowledge and experience helps us to meet our clients’ needs both locally and abroad.

Our clients:
  • Air Liquide
  • Airbus (EADS)
  • EBRD
  • Kazakhtelecom
  • Mining International Company
  • Samruk Energy
  • Samruk Kazyna
  • Samsung
Our partners:
  • Allen & Overy
  • Chadbourne & Parke
  • Cleary Gottlieb Steen & Hamilton
  • Clifford Chance
  • Clyde & Co
  • DLA Piper
  • Freshfields Bruckhaus Deringer
  • Gide Loyrette Nouel
  • Herbert Smith Freehills
  • Hogan Lovells
  • Jones Day
  • Latham & Watkins
  • Linklaters
  • Orrick
  • Proskauer Rose
  • Simmons & Simmons
  • Skadden, Arps, Slate, Meagher & Flom
  • Slaugther & May
  • Squire Sanders
  • SJ Berwin (King & Wood Mallesons)